Jayantha Gunaratne

Title: Jayantha Gunaratne: Innovator in Bladder Cancer Biomarkers

Introduction

Jayantha Gunaratne is a prominent inventor based in Singapore, known for his significant contributions to the field of medical research. His work primarily focuses on the development of biomarkers for bladder cancer, which has the potential to improve diagnostic methods and patient outcomes.

Latest Patents

Gunaratne holds a patent for bladder carcinoma biomarkers. This patent discloses various protein biomarkers that can determine whether a patient suffers from or shows recurrence of bladder cancer. The biomarkers can also indicate early or late stages of the disease. The detection system and associated kits utilize these biomarkers, which include Coronin-IA, Apolipoprotein A-IV, Semenogelin-2, Gamma-synuclein, and DJ-1, along with their variants. He has 1 patent to his name.

Career Highlights

Jayantha Gunaratne is affiliated with the Agency for Science, Technology and Research, where he conducts his research and development activities. His work has garnered attention for its innovative approach to cancer diagnostics, making a significant impact in the medical community.

Collaborations

Gunaratne collaborates with notable colleagues, including Jean Paul Thiery and Prashant Kumar. Their combined expertise enhances the research efforts in the field of cancer biomarkers.

Conclusion

Jayantha Gunaratne's contributions to bladder cancer research exemplify the importance of innovation in medical science. His work not only advances the understanding of cancer biomarkers but also holds promise for improving patient care and treatment strategies.